Bixiye
2022 May Bulletins
Taariikhda uu dhaqangalayo Barnaamijka: May 02, 2022
Natiijooyinka Raadinta
Soo bandhiga 1761 - 1770 ee natiijooyinka 3688
Bixiye
Vascepa® (icosapent ethyl) - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2024
Bixiye
P35-22 Medical Policy Updates: Coupe Health and Self-Funded Benefit Plans managed by Blue Cross and Blue Shield of Alabama
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2022
Bixiye
Opioids Immediate Release (IR) and Extended Release (ER) New To Therapy with Daily Quantity Limit - Medicaid
Quantity Limit
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2025
Bixiye
QP36-22 Commercial Pharmacy Benefit Exclusion for Xolair®
Taariikhda uu dhaqangalayo Barnaamijka: May 11, 2022
Bixiye
QP37-22 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: VoxzogoTM (vosoritide)
Taariikhda uu dhaqangalayo Barnaamijka: May 11, 2022
Bixiye
QP38-22 Updates to Authorization Request with Unlisted or Unspecified Codes
Taariikhda uu dhaqangalayo Barnaamijka: May 11, 2022
Bixiye
P32-22 Medical Policy Updates: Coupe Health and Self-Funded Benefit Plans managed by Blue Cross and Blue Shield of Alabama
Taariikhda uu dhaqangalayo Barnaamijka: May 02, 2022
Bixiye
P33-22 New Medical, Medical Drug and Behavioral Health Policy Management Updates—Effective July 4, 2022
Taariikhda uu dhaqangalayo Barnaamijka: May 02, 2022
Bixiye
P30-22 eviCore Healthcare Specialty Utilization Management (UM) Program – Medical Oncology Drug Prior Authorization Updates
Taariikhda uu dhaqangalayo Barnaamijka: May 02, 2022